首页 / 产品中心 / 多克隆抗体 /

货号: YP-Ab-17896
促销价:

产品介绍

反应种属
Human,Mouse,Rat
应用范围
WB Cited IF (Human)
抗体类型
多克隆抗体
基因名称(Gene Name)
MAP1LC3A/MAP1LC3B
蛋白名称
分子量(DA)
Calculated MW: 14 kDa; Observed MW: 14,16 kDa
免疫原
Synthetic peptide.
特异性
组成
来源
稀释比例
WB: 1/500-1/1000
纯化工艺
浓度
储存
-20°C long term. Avoid freeze/thaw cycles.
其他名称
LC3; LC3A; ATG8E; MAP1ALC3; MAP1BLC3; MAP1LC3A; LC3B; ATG8F; MAP1LC3B-a; MAP1A/1BLC3; MAP1LC3B
背景
Macroautophagy is the major inducible pathway for the general turnover of cytoplasmic constituents in eukaryotic cells, it is also responsible for the degradation of active cytoplasmic enzymes and organelles during nutrient starvation. Macroautophagy involves the formation of double-membrane bound autophagosomes which enclose the cytoplasmic constituent targeted for degradation in a membrane bound structure, which then fuse with the lysosome (or vacuole) releasing a single-membrane bound autophagic bodies which are then degraded within the lysosome (or vacuole). MAP1A and MAP1B are microtubule-associated proteins which mediate the physical interactions between microtubules and components of the cytoskeleton. These proteins are involved in formation of autophagosomal vacuoles (autophagosomes). MAP1A and MAP1B each consist of a heavy chain subunit and multiple light chain subunits. MAP1LC3a is one of the light chain subunits and can associate with either MAP1A or MAP1B. The precursor molecule is cleaved by APG4B/ATG4B to form the cytosolic form, LC3-I. This is activated by APG7L/ATG7, transferred to ATG3 and conjugated to phospholipid to form the membrane-bound form, LC3-II.
功能

展开

产品详情

客户数据及评论 (0)

折叠内容

文献引用

折叠内容

实验方案

折叠内容
>